Quilizumab (
INN) is a humanized monoclonal antibody designed for the treatment of
asthma. It binds to
IGHE.
This drug was developed by
Genentech
Genentech, Inc., is an American biotechnology corporation headquartered in South San Francisco, California. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within R ...
.
References
Monoclonal antibodies
Hoffmann-La Roche brands
Genentech brands
{{monoclonal-antibody-stub